![Frederick B. Oleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick B. Oleson
Corporate Officer/Principal bei
CUBIST PHARMACEUTICALS INC
Profil
Frederick B. Oleson is currently the Vice President-Non-Clinical Development at Cubist Pharmaceuticals LLC since 1997.
Prior to this, he worked as the Director-Toxcology & Preclinical Pharmacology at Biogen MA, Inc. from 1992 to 1997, and as the Director-Investigative Toxicology at Bristol Myers Squibb Co. from 1983 to 1992.
He also briefly worked as the Director-Preclinical Research at AutoImmune, Inc. in 1997.
Oleson completed his undergraduate degree at Princeton University and his graduate and doctorate degrees at Harvard T.H.
Chan School of Public Health.
Aktive Positionen von Frederick B. Oleson
| Unternehmen | Position | Beginn |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.1997 |
Ehemalige bekannte Positionen von Frederick B. Oleson
| Unternehmen | Position | Ende |
|---|---|---|
AutoImmune, Inc.
 AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Corporate Officer/Principal | 01.06.1997 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Corporate Officer/Principal | 01.01.1997 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1992 |
Ausbildung von Frederick B. Oleson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
